Monthly Newsletter Banner - January 2026

Inventia Life Science | The Culture Newsletter
The Cancer & Tumor Microenvironment Edition

 

Welcome to the January edition of The Culture, our monthly roundup of scientific insights, practical resources, and real-world applications of 3D biology.

This month, we are focusing on how high-fidelity 3D cancer models are reshaping drug discovery and translational oncology, particularly in the context of the tumor microenvironment. From new publications and blog features to practical guides and on-demand learning, this edition highlights tools and data designed to help researchers scale biologically relevant models with confidence.

 

 

Inventia Insights

Inventia Insights: User Stories and Guides from the Blog 

 

New!  RASTRUM Cloud: Easily Design Advanced 3D Cell Models
Explore how RASTRUM Cloud supports reproducible, scalable 3D model development by unifying experimental design, execution, and data context across cancer research workflows.
Learn more →

New! Unlocking New Phenotypic Insight in 3D Drug Discovery: How RASTRUM™ Allegro and ViQi AutoHCS™ Reveal What Traditional Workflows Miss
Learn how ViQi and Inventia are working together to streamline image-based analysis from 3D cell models, helping researchers extract deeper insight from complex tumor microenvironment data.
Explore the collaboration →

ICYMI: Building Patient-Specific Drug Screens in Weeks, Not Months: A New Model for Precision Oncology
Learn how scalable 3D cell models are enabling faster, patient-relevant drug screening workflows for precision oncology, without sacrificing biological fidelity.
Read the full story →

 

 

 

marsh-trial-repurposing-publication

Publication Spotlight: Repurposing of ivacaftor shows potential to treat ROR1 expressing high-grade serous ovarian cancer

 

This newly published study highlights how advanced 3D cell models can reveal drug response patterns that more closely reflect patient-derived systems, supporting translational decision-making in oncology research.

Read the publication →

 

 

 

Thumbnail of a product guide titled "The Tumor Microenvironment in Phenotypic Drug Discovery," featuring a fluorescent image of a tumor model on the cover. This guide discusses key considerations for using 3D cell models in drug discovery research.

Resource Spotlight: The Tumor Microenvironment in Phenotypic Drug Discovery


This practical guide outlines key considerations for building scalable, biologically relevant 3D tumor models, including matrix-embedded architectures, tumor–stromal interactions, and assay compatibility.


Download the guide →

 

 

 

BMS Poster SLAS 2025 image

Poster Spotlight: Development of a reproducible, high-throughput, and screenable 3D PDAC model using the RASTRUM™ platform


See how advanced 3D models were used to generate thousands of pancreatic cancer model replicates with low technical variation and robust drug response data in high-throughput formats.

View the poster →

 

 

 

At Inventia Life Science, we’re shaping the future of 3D cell biology, and we want you to be part of the journey.